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Abstract
Background: The treatments for spinal tuberculosis (TB) patients without absolute surgical indications have been
controversial. Some people believed that most spinal TB patients were indicated for surgery, while other people
believed in chemotherapy only. To help clarify the treatment over spinal TB patients without absolute surgical
indications, we characterized a subtype spinal TB and then analyzed the treatment outcomes of standard
chemotherapy alone.
Methods: In this retrospective study, 740 adult patients of spinal TB from January 2005 to January 2013 in our
institution were reviewed. Patients who fit into the characterizations of mild spinal TB were started by standard
chemotherapy for 18 months and followed up for at least 2 years upon the completion of treatment. The overall
outcome, neurological function, local kyphosis, and level of pain at different time points were assessed.
Results: After starting the conservative treatment, 89 out of 740 patients were chosen for chemotherapy alone, and
all patients were followed up for at least 2 years (ranging from 24 to 50 months) upon the completion of the
treatment. Of 89 patients, 95.4 % of patients showed a definite and clinical response within 1 month after starting
the treatment, 69 % of patients had excellent to good results, with no complications of the disease, and 77.5 % had
asymptomatic local kyphosis with intact neurological function; solid bony fusion of adjacent segment was achieved
in 88.8 % of patients.
Conclusions: We believe that the mild spinal TB respond well to the standard chemotherapy, and the detailed
description of mild TB would provide crucial guidance in determination of conservative treatment.
Keywords: Mild spinal tuberculosis, Standard chemotherapy alone, Treatment outcome
Background
The World Health Organization reports that China
ranks second among the 22 countries with the highest
burden of tuberculosis [1]. Spinal tuberculosis (TB) is
the most common form of extrapulmonary tuberculosis,
accounting for approximately 1 to 3 % of all tuberculosis
cases [2].
The management for spinal TB includes conservative
and operative treatments. So far, the absolute surgical in-
dications for spinal TB include (1) progressive neuro-
logic deficit, (2) progressive increase in spinal deformity
(coronal or sagittal) (3) failed conservative treatment in-
cluding 1 and 2 above or severe pain due to abscess or
spinal instability, and (4) uncertain diagnosis: this could
be an inability to obtain microbiological diagnosis from
microscopy, culture, or even via detection of mycobac-
terium DNA using polymerase chain reaction (PCR)
techniques [3]. Meanwhile, there is no agreement upon
the indications of conservative treatment. Several classi-
fications have been proposed to help with the determin-
ation, and most spinal TB patients were recommended
for surgery accordingly. On the other hand, however, re-
cent literatures questioned the efficacy of surgery in im-
proving the outcomes of spinal TB [4].
Fundamentally, the treatment of tuberculosis is by
chemotherapy and surgery attempts only to extirpate the
complications arising from the disease process. Hence,
most cases of spinal TB merit medical rather than surgi-
cal treatment, especially the mild spinal TB.
In the present study, we sought to clarify the indica-
tions of conservative treatment for spinal TB by
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analyzing the outcomes of mild spinal TB cases treated
by nonoperative methods in our center.
Methods
A retrospective study was made of 740 consecutive adult
patients with spinal TB who were diagnosed and treated
in our center from January 2005 to January 2013. The
diagnosis of spinal TB was made upon the medical his-
tory, clinical manifestations, radiology, lab tests, and
histology samples if possible. Only patients who started
conservative treatment when they were presented to our
clinic were included in our study. The indications of
conservative treatment included (1) mild to moderate
neurologic deficit (no less than American Spinal Injury
Association (ASIA) D), (2) single vertebral involvement
with central lesion or multivertebral involvement (less
than 3) with edge type lesion, (3) vertebral accessory tu-
berculosis without spinal canal involvement, (4) verte-
bral body collapse less than 1/3 of total height, (5)
limited range of paravertebral abscess (within one level
vertebrae, no retropharyngeal abscess, or psoas abscess),
(6) no significant kyphosis (less than 30°), and (7) no sig-
nificant intervertebral instability [5] (a sagittal plane dis-
placement greater than 2.5 mm in the thoracic spine as
demonstrated on lateral radiographs was considered po-
tentially unstable, a sagittal plane displacement greater
than 4.5 mm in the lumbar spine, or 15 % of the antero-
posterior diameter of the vertebral body as demonstrated
on a static lateral radiograph, was considered potentially
unstable). The contraindications for conservative treat-
ments included skeletal immaturity, pregnancy at the
time of treatment, intracanal tumor or metastatic tumor,
poor compliance to treatment due to mental conditions,
and significantly impaired hepatic function (alanine ami-
notransferase, ALT and aspartate aminotransferase, AST
higher than two times of normal level).
Patients who met all the above criteria were treated con-
servatively, and patients with deteriorating neurologic
function (worse than ASIA D) or progressive kyphosis
(greater than 40°) while on anti-tuberculosis chemother-
apy were considered for surgical treatments. Approval
from our institutional review board was obtained for the
study. A written informed consent was obtained from each
of the patients authorizing treatment, radiographic examin-
ation, and photographic documentation and publishing the
above data in academic studies.
Detailed medical history and physical examination were
acquired for each patient; neurological status was evaluated
at each follow-up visit. Muscle power was examined and
scored from 0 to 5 according to the Medical Research
Council scale. Spinal cord function was evaluated using
ASIA definitions. Muscle tone, reflexes, pinprick sensations,
joint position, and vibration were tested, and the presence
of bone deformity and soft-tissue tenderness or swelling
was also recorded. Radiology including plain X-rays, CT,
and MR was used to evaluate spinal features such as osteo-
penia, paravertebral abscess, disc space reduction, and end-
plate erosion, as well as gross vertebral and costovertebral
bone destruction and deformities. In addition, the following
lab tests were done for each patient in the first visit:
complete blood count, erythrocyte sedimentation rate
(ESR), liver function, and HIV serology. Liver function and
ESR were monitored at each follow-up after the drug ad-
ministration. Localized spinal deformity was measured as
the angle between the upper and lower endplates of the col-
lapsed vertebral levels using the Cobb method. Radiological
evaluation was made before treatment and at each follow-
up visit.
Treatment protocol
1. Chemotherapeutic agents were administered using a
standard protocol. Patients were treated with a
standard four-drug treatment that included rifampicin
(15 mg/kg; maximum 600 mg/day), isoniazid (5 mg/kg;
maximum 300 mg/day), pyrazinamide (25 mg/kg;
maximum 2 g/day), and ethambutol (15–25 mg/kg;
maximum 2 g/day)for 18 months [6].
2. Plain X-rays and MRI scans/CT scans and blood
tests, as mentioned previously, were performed at 1,
3, 6, 9, 12, 18, 24, 30, and 42 months after starting
the treatment to monitor response to treatment.
3. Patients who were ambulatory at the time of
diagnosis were kept ambulatory during treatment,
with restriction of heavy, load-bearing, contact
activities. Patients who were bedridden at the time
of diagnosis were kept in bed until clinical recovery
(pain relief and neurological improvement) and then
mobilized and ambulated with similar precautions as
the ambulatory group, that is, with restrictions in
heavy activity. Ambulation was permitted in these
patients at an average of 3 to 4 weeks, and return to
activities of daily living, light work, and noncontact
activity was possible at 6 to 12 weeks, depending on
the clinical response to treatment.
4. Information regarding treatment risks, such as death
and morbidity, and the risks of chemotherapeutic
management was provided to the patients. Patients
were followed up at 1, 3, 6, 9, 12, 18, 24, 30, and
42 months after starting the therapy. Patients’
families were also given education about the
importance of drug administration according to the
protocol and adverse events related to the chemo
agents [6].
Ethics
This study was approved by the Institutional Review
Board (IRB) of Southwest Hospital, Third Military
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Medical University. All procedures in the study were in
accordance with the ethical standards of the IRB of
Southwest Hospital and with the Helsinki Declaration.
Results
After starting the conservative treatment, 89 out of 740
patients were chosen for chemotherapy alone, and all
patients were followed up for at least 2 years (ranging
from 24 to 50 months) upon the completion of the treat-
ment. Of the 89 patients, 34 (52 %) of the patients were
female and 55(48 %) were male, with a mean age of
28.08 years (range 15–78 years). Two patients were
treated by standard anti-tuberculosis treatment protocol
because of pulmonary TB for 24 months, and they had
fully recovered for at least 5 years before being presented
to our center due to spinal TB. Symptoms reported in
the first visit included back pain, sweating, and fever,
which were summarized in the table (Table 1). The in-
volved spinal locations were the cervical spine in 2 pa-
tients (2.2 %), the thoracic spine in 21 (23.6 %), the
thoracolumbar junction in 14 (15.7 %), the lumbar spine
in 50 (56.2 %), and the sacral region in 2 (2.2 %). The
most commonly affected vertebra was L4 in 23 cases
(25.8 %), followed by L3 in 15 cases (16.9 %). Of all pa-
tients, 81 (91 %) had intervertebral destruction, 56
(62.92 %) had prevertebral or paravertebral abscesses,
and 69 (77.53 %) had significant local kyphosis due to
the collapse of the anterior column. No patients had epi-
dural compression or spinal cord abscess. Of the cases
with abscess, 25 (28.09 %) were larger than 6 cm and 22
(24.72 %) were larger than 4 cm in diameter. As indi-
cated on MR images, a single vertebra was involved in
five patients (5.62 %), two vertebrae in 78 (87.64 %), and
three vertebra in 6 (6.74 %) patients. No patient had pul-
monary or lymph node tuberculosis.
After beginning conservative medical management, 85
(95.4 %) of the 89 patients showed definite and persist-
ent clinical response within 1 month, which was con-
firmed by radiological findings and blood tests. One year
after the completion of treatment, the mean VAS score
had improved from a pretreatment score of 7.6 to a
posttreatment score of 1.7 (p < 0.001, paired sample t
test), accompanied by complete resolution of pretreat-
ment symptoms. Two years after the completion of
treatment, the average VAS score was 0. Muscle strength
was normal in 78 patients (91.76 %) with an ASIA grade
of E, but hyperflaxia of tendon reflexes were present in
some of these patients.
Four patients (4.5 %) did not respond to the four first-
line drugs in the first month, and in the third month
follow-up, they complained of severe back pain (average
VAS 8.5); they also exhibited neurological deficits which
were given an ASIA grade of D. The radiology showed
significant progression of the vertebral destruction and
paraverterbal abscess. Those patients were then treated
with surgical correction, bone grafting, and chemother-
apy with second-line drugs. Consequently, the outcomes
of the four patients were not included in the following
analysis.
The Cobb angles of the local kyphosis before and
2 years after completion of treatment were compared.
The average angulations were found to have increased
significantly from 6.25 ± 3.11°(range 10°–32°) to 12.36 ±
6.31°(p < 0.05, paired sample t test). A regression of
spondylodiscitis and abscess absorption was a sign of re-
covery as demonstrated on MR images; nine cases
(10.59 %) showed total recovery of vertebral body and
vertebral disc according to the radiological image
(Fig. 1.). Seventy-nine (87.05 %) showed spontaneous
spinal fusion between the destructed vertebral and adja-
cent levels; 69 (81.18 %) had asymptomatic local ky-
phosis with intact neurological function (Fig. 2). As to
the adverse effects of chemotherapy, 11 (12.94 %) had
transient gastrointestinal reaction (nausea and vomiting)
after the first week of chemotherapy, which then re-
solved after medications of antiemetics. Five cases
(5.88 %) showed elevated ALT (three times higher than
normal level) and AST (two times higher than normal
level) in one visit and went back to normal after hepato-
protective treatment. There were no reports of optic
nerve or auditory nerve injury due to the chemotherapy.
Finally, according to the results above, we modified a
previous scoring system [7] and classified the outcomes
into four categories by considering the following criteria:
1. Normal body temperature and ESR, negative sign of
all pretreatment symptoms
2. No presence of sinus or abscess
3. Intact neurological function
4. Complete regression or calcification of lesion focus
on CT/MRI scan
5. Primary-line four-drug anti-tuberculosis medica-
tions, used throughout the 18 months
6. More than four drugs used, for longer than
18 months
7. Progression of kyphosis over 10° at affected level at
the end of treatment
8. Failure of nonoperative treatment, requiring surgical
intervention
The four categories are as follows:
Excellent result: complete resolution of disease with first-
line anti-tuberculosis treatment for 18 months, with no
residues or side effects of treatment (criteria 1, 2, 3, 4, 5)
Good result: complete resolution of disease with first-
line treatment for longer than 18 months, or with
second-line drugs for 12 months or longer, with or
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without the occurrence of medically manageable side
effects of drug therapy, such as gastrointestinal intolerance
and drug-induced jaundice, necessitating frequent
manipulations in their doses and regimen, but with
eventual complete resolution (criteria 1, 2, 4, 6)
Fair result: complete resolution of disease, but with
increased kyphosis of 10° or more at the affected level
with no obvious or mild neurological compromising
(criteria 1, 2, 3/4/5/6, 7)
Poor result: cases that did not respond to conservative
treatment, primary or secondary line, and had to be
eventually operated (criteria 8)
The results of our series of 89 cases are shown in
Table 2. Thus, excellent to good results were seen in
over 69.66 % of our patients, with nonsurgical treatment.
The 25.84 % with fair results also resumed routine activ-
ities of work and daily living without physical restric-
tions or need for regular analgesic medications, despite
residual kyphosis. Four patients (4.49 %) who were
treated surgically were classified as poor.
Discussion
The World Health Organization reports that China
ranks second among the 22 countries with the highest
burden of tuberculosis; spinal TB is the most common
form of extrapulmonary tuberculosis and remains a se-
vere public health threat in China [1].
The indication of conservative treatment for spinal TB
is a continuing matter of debate. Historically, the
chemotherapy was considered as the only effective way
of treating spinal TB, until Hodgsonet al. [8] advocated
progressive surgical intervention. Later on, to solve the
debate upon the treatment choice, the British Medical
Research Council (BMRC) have initiated a series of clin-
ical trials since 1970, the trial included two branches,
the Korea and Hongkong branches. In Korea, 350 pa-
tients of spinal TB were enrolled for the medical man-
agement, and in Hongkong, 150 patients all underwent
surgery. Though the disease was more extensive in
Korea, the great majority of patients in both countries
achieved a favorable status at 15-year follow-up [9]. Yet,
on finishing the trial, they concluded that the surgical
group had best results because these patients had more
rapid abscess resolution and earlier and more frequent
bone fusion [10]. Obviously, the lack of universal
Table 1 The main symptoms, radiological data and lab results











Night sweat 33 (37.08)




Percussion pain 88 (98.88)
Local deformity 10 (11.24)
Sinus 2 (2.25)









Disc space destruction 81 (91.01)
Paravertebral abscess 56 (62.92)
Local kyphosis 69 (77.53)








Pretreatment (ASIA D) 11 (12.4)
Posttreatment (ASIA D) 6 (6.7)
Pretreatment (ASIA E) 78 (87.6)
Posttreatment (ASIA E) 83 (93.3)
Kyphosis (°)
Pretreatment 6.2 ± 3.11°
Posttreatment 14.36 ± 6.31°
Table 1 The main symptoms, radiological data and lab results
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inclusion criteria and sample balance of trial branches
have weakened the credibility of this conclusion. Re-
cently, Chandra et al. described their paradigms of
management, in which they claimed that radical, in-
strumented surgeries should be offered in an early stage
[11]. Though the surgical intervention may have several
advantages [3, 4, 12–14], it requires expertise, good
anesthesia, and excellent perioperative care. It also re-
quires hospitalization and is expensive and potentially
dangerous. Complications can occur during the oper-
ation or postoperatively, which include reconstruction-
related, vascular, neurological, visceral, and wound-
related complications [3, 15–18]. Reconstruction
failures can be breakage of the graft, screws, and rods,
loss of correction, and failure of fusion [19]. Vascular
problems during surgery can be massive bleeding,
hematoma formation, and thromboembolism. Neuro-
logical damage of surgery can be nerve root lesion,
dura tears, spinal cord infarction, and plexus lesions.
Visceral damage, especially ureteric lesions, can occur.
Wound infections happen in 1 to 6 % of spinal surger-
ies [17].
Meanwhile, Tuli et al. [20] believed a combined
method in treating the spinal TB and they advocated a
“middle path” regimen, which included a less radical sur-
gery along with chemotherapy, but they did not come
up with a clear cut protocol to distinguish the surgical
candidates from those who do not need surgeries.
As a result, several classifications were proposed for
clinical decisions. Mehta and Bohjraj [21] proposed a
system based on MRI appearance; however, they did not
have a subtype for conservative treatment. Oguz et al.
[22] came up with a classification based on the size and
location of the lesion, in which they believed only pa-
tients with one level vertebral involvement, no neuro-
logical deficit, no collapse, and no abscess could be
Fig. 1 These are radiology data for a 44-year-old female with mild spinal tuberculosis at L1/L2 and L4/L5. The patient was treated with standard
first-line antituberculosis drugs for 18 months. a The lateral view of X-ray shows that, before the treatment, there was bone destruction between
the L1/L2 and L4/L5 vertebral (arrow) and the Cobb angles (yellow lines) for the local kyphosis were 20.3° and 10.5°, respectively. The anterior and
posterior views show significant intervertebral space reduction (arrow) of L1/L2 and L4/L5. b The CT images before the treatment show bone
destruction and intervertebral space reduction (arrows) at L1/L2 and L4/L5 levels, and the Cobb angles (yellow lines) of kyphosis were 22.6° and
8.5°, respectively. c The MRI images before the treatment show significant edema and absence of normal intervertebral signal at L1/L2 and L4/L5
level (arrows), but there is no compression on the spinal cord or nerve roots. d The anterior posterior and lateral views of X-ray show that, after
18 months of standard chemotherapy of first-line drugs, there is no progression of bone destruction or vertebral collapse, and there is formation
of bonny bridging (arrows) between the L1 and L2 vertebra, which indicated possible simultaneous spinal fusion. The Cobb angles of local kyphosis
(yellow lines) were 20.8° and 11.3°, respectively. e Two years after the 18-month standard chemotherapy treatment, the CT images show solid fusion at
the L1/L2 and l4/L5 levels, and the Cobb angles of local kyphosis (yellow lines) were 19.8°and 9.8°, respectively. There was no significant progression of
local kyphosis compared to those of pretreatment
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treated by drug therapy alone. Unfortunately, some re-
cent studies have proved that patients with larger lesions
and certain degrees of neurological deficit could be suc-
cessfully treated with nonoperative methods. Nene and
Bhojraj [7] showed in their study that 98 % in their series
could be treated conservatively. Kotil et al. [23] did a
prospective study on patients without major neurological
deficits or severe spinal deformities (kyphotic angles
smaller than 30°). Forty-two (95.4 %) of the 44 patients
were successfully treated with conservative medical
management and attained acceptable spinal deformity
angles. In a prospective study, Ahmed Bakhsh [6] in-
cluded 26 patients with spinal TB who were followed up
for 12 months. Eighty-five percent of cases completely
improved on medical treatment without any surgical
intervention. Nene and Bhojraj [7] assessed the efficacy
and results of nonsurgical treatment in thoracic spinal
TB in adult patients in a retrospective analysis of 70
adults with thoracic spinal TB. Over 98 % of the patients
(69 of 70) were successfully treated conservatively.
Seventy-four percent had excellent to good results, with
no mechanical residues of the disease.
To clarify the indications for conservative treatment,
we characterized a subtype spinal TB, which were most
likely to benefit from medical treatment. Furthermore,
we have come up with an all-inclusive evaluation system
to verify the efficacy of medical treatment alone.
In our study, we characterized a subtype spinal TB,
which is the “mild spinal TB” in great detail and selected
the study population accordingly. As shown in Table 1,
the enrolled patients were all skeletal matured and had
less than 30° kyphosis with mild to moderate neuro-
logical deficit. As to the location of lesion, the most
commonly affected levels were lumbar segments
(56.2 %); the least affected were sacral and cervical. This
might have to do with the neurological status at pres-
ence; as in the lumbar region, the nerve roots are more
tolerant to the spinal deformity or vertebral collapse,
while the cervical segments are more sensitive and display
worse neurological deficit. This was unlike the previous
studies, in which thoracic or thoracic lumbar were the
most commonly involved segments [6, 11, 19, 23–26].
Deformity or kyphosis is a significant problem in Pott’s
disease. Kotil et al. [23] reported that the mean local spine
deformity angle had increased from 11° (range 5°–19°)
before medical treatment to 21° (range 10°–32°) after
treatment. Nene and Bhojraj [7] found that the progres-
sion of local kyphosis ranged from 0° to 40° at the 2-year
follow-up, though the initial thoracic kyphosis of all pa-
tients was less than 30°. In the BMRC trail [9], the authors
found the progression between 8° and 16° at 36-month
follow-up. In our results, however, after 18 months of
standard chemotherapy, the mean local kyphosis had in-
creased from 6.25 at first visit to 14.36 at 24-month
Table 2 The outcomes of our series of 89 cases






Fig. 2 This is a 34-year-old male who was diagnosed of mild spinal tuberculosis (L5/S1) with sacral abscess; the patient was treated with standard
chemotherapy for 18 months. a The MRI before the treatment shows an intervertebral edema of L5/S1 and the formation of sacral abscess anteriorly
(arrow); the Cobb angle of local lordosis (yellow lines) was 33.4°. b The MRI after 5 years shows complete absence of sacral abscess and the intervertebral
edema, and the Cobb angle of local lordosis (yellow lines) was 31.5°; there was no significant progression of local kyphosis or simultaneous spinal fusion
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follow-up, which was less than the progression in the liter-
atures. Rajasekaran et al. [27] reported that the progress of
deformity occurs in two distinct phases: phase I includes
the changes in the active phase, and phase II includes
changes after the disease is cured. The deformity progres-
sion is influenced by the severity of the angle before treat-
ment, the level of the lesion, and the age of the patient.
Therefore, the limited progression in our study could be
explained by the following reasons: first, all the patients
had a mild initial kyphosis and they were all skeletal ma-
ture. Furthermore, the long-term standard chemotherapy
has been carried out effectively to ensure the elimination
of the lesion. And last but not least, most involved vertebra
were lumbar segments, which was unlike the previous liter-
atures in which thoracic lumbar segments were most com-
monly involved [6, 11, 19, 23–26], this also indicated that
patients with lumbar involvement tend to have less ky-
photic progression. Different degrees of neurological im-
provements were reported in the literature [7, 24, 28–30].
Yet in our study, we did not see dramatic improvement
of the neurological status for most patients at the end
of 2-year follow-up. The reason could be because we
only included patients with mild to moderate neuro-
logical deficit (ASIA D and E) and there were no pa-
tients with any intracanal abscess or spinal cord
involvement. It is believed that the back pain could be
caused by the compression of the paraverterbal abscess;
therefore, the resolution of the perivertebral abscess
could lead to significant pain relief [7, 12, 29, 30]. And
most patients in our study have achieved significant
pain relief after 12 months of chemotherapy and con-
tinued to get better at the end of the 24-month follow-
up, though there was no significant difference between
the results of 12 and 24 months.
Our study is not without limitations. Though most
patients responded to the standard chemotherapy,
four of them showed progression of the neurological
deficit and back pain, which later were proved to be
infected by drug-resistant mycobacterium. The failure
of these cases emphasized the importance of drug sus-
ceptibility tests in the early stage of treatment. In our
center, we have implemented DNA microarray for de-
tection of isoniazid (INH) and rifampicin (RMP) re-
sistance strains, which proved to be an accurate and
rapid method [31]. That is why all the failed cases
were all before 2008, when we began to implement the
DNA microarray as routine tests for spinal TB
patients.
Conclusions
The mild spinal TB could be treated by standard
chemotherapy alone. Surgery should be reserved for
cases which do not respond well to chemotherapy. If
the angle of spinal deformity and neurological deficits
are within acceptable limits, medical management
alone is sufficient enough.
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